Armada announces Myrtle Potter will join Summit lineup, adds pre-conference session
FLORHAM PARK, N.J. — Armada Health Care on Thursday added featured speaker Myrtle Potter to its card at the 2014 Specialty Pharmacy Summit and Expo to be held in Las Vegas May 5 to 9. The specialty pharmacy group also announced the addition of a pre-conference seminar/workshop to take place on May 5 and 6.
Potter will join a speaker faculty of more than 50 other industry experts at this conference with a presentation titled, "Healthcare Leaders: How Will You Successfully Navigate the Healthcare Storm?".
Potter has dedicated three decades to serving the needs of patients through her leadership of some of America's most successful global healthcare companies. She is an active board member on the boards of Rite Aid, Liberty Mutual Holding Company, Everyday Health and Proteus Digital Health. Potter founded Myrtle Potter & Co. and has served as president and COO commercial operations for Genentech and president of the U.S. Cardiovascular and Metabolic Business for Bristol-Myers Squibb. She has also served on the boards of Express Scripts, Medco Health Solutions and Amazon.
Her experience with large consumer, pharmaceutical and biotechnology companies has earned her a reputation as the "Trusted Voice in Healthcare," Armada reported.
Armada also announced an additional pre-conference seminar/workshop to take place on May 5 and 6. This seminar will provide its audience with an in-depth understanding of the dynamics that drive the specialty pharmacy industry, including an historical and future market analysis, the channel structure and the unique specialty pharmacy service model. It will conclude with an interactive Q&A session with an expert specialty pharmacy executive panel, highlighting opportunities in this marketplace.
"For more than 10 years, Armada has been leading the industry by pioneering contracts and solutions for the specialty pharmacy market," said Armada president Robert Irene. "This newly added seminar will offer a unique and in-depth understanding of the specialty pharmacy model, which will provide valuable insight into this trade class and drive continued collaboration."